Product
HH-003
4 clinical trials
3 indications
Indication
Chronic Hepatitis B InfectionIndication
Chronic Hepatitis BClinical trial
A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple-dose HH-003 Injection in Treatment Naïve Participants With HBeAg-positive Chronic HBV InfectionStatus: Completed, Estimated PCD: 2022-03-15
Clinical trial
An Open-label Phase IIa Study to Evaluate the Antiviral Effect and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and D Co-infectionStatus: Terminated, Estimated PCD: 2022-07-25
Clinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 in Nucleos(t)Ide Analogues-treated Chronic Hepatitis B Subjects With Low-Level ViremiaStatus: Active (not recruiting), Estimated PCD: 2023-04-24
Clinical trial
A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase InhibitorsStatus: Completed, Estimated PCD: 2022-12-05